Skip to main content

Advertisement

Table 1 Patients’ background demographic and clinical characteristics at the time of breast cancer diagnosis (n = 280)

From: Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy

  No. of patients %
Age at breast cancer diagnosis
  ≤ 35 41 14.6
 36–40 82 29.3
 41–45 157 56.1
Height- median; range (cm) 159 (141–175)  
Weight- median; range (kg) 54.6 (39.0–89.0)
BMI at diagnosis (according to HK BMI)
 Underweight (<18.5) 33 11.8
 Normal (18.5–22.9) 155 55.4
 Overweight (23.0–24.9) 46 16.4
 Obese (>25) 46 16.4
1 or more children born before breast cancer diagnosis 205 73.2
Ever smoking 10 3.6
Ever excessive alcohol intake (> 2 units/day) 1 0.4
Education
 Primary 47 16.9
 Secondary 187 67.0
 Tertiary 27 9.7
 Higher qualification 18 6.5
Employment
 Retired 3 1.1
 Unemployed 105 37.5
 Full Time 127 45.3
 Part Time 45 16.1
Family income
 < HK$5000 27 9.6
 HK$5000–25,000 150 53.6
 HK$25000–50,000 83 29.6
 HK$50,000 20 7.2
1st degree relative with breast cancer 17 6.1
T stage
 T1 140 50.0
 T2 133 47.5
 T3 7 2.5
 T4 0 0
Nodal Status- positive 114 40.7
TNM staging:
 Stage I 88 31.4
 Stage II 165 58.9
 Stage IIIa 27 9.6
ER positive 203 72.5
PR positive 187 66.8
HER2 over-expression 47 16.8
Breast surgery:
 Lumpectomy 95 33.9
 Mastectomy 185 66.1
Axillary lymph node dissection 276 98.6
Received adjuvant radiotherapy 186 66.4
Adjuvant chemotherapy regimen:
 Non-anthracycline and non-taxane containing 17 6.1
 Anthracycline-containing 184 65.7
 Taxane-containing 5 1.8
 Anthracycline- and taxane-containing 74 26.4
Duration of adjuvant chemotherapy >64 days 191 68.2
Received corticosteroid premedication during chemotherapy 258 92.1
Received adjuvant tamoxifen 214 76.4
Received adjuvant trastuzumab 8 2.9
Use of traditional Chinese medicine since diagnosis 83 29.6